Table 1. Evaluation of CXCR4 expression with flow cytometric analysis and IHC.
MFIR CXCR4+ and CXCR4++ population | Ratio MFIR MIN-O/4T1 | Ratio membranous staining MIN-O/4T1 (ex vivo) | |
MIN-O (early stage) | 165.5±13.8 | 1.8 | 1.1 |
MIN-O (intermediate stage) | 329.6±33.6 | 3.6 | 3.5 |
MIN-O (late stage) | 367.9±22.4 | 4.0 | 5.5 |
4T1 | 91.5±14.4 | - | - |
For MIN-O tumor tissue, 6 biopsy samples per stage were evaluated. Also, n = 6 4T1 biopsy samples were assessed. All samples were evaluated in triplicate. MFIR: mean fluorescent intensity ratio. Ratio of membranous staining calculated from data reported in [15].